SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-075232
Filing Date
2023-03-21
Accepted
2023-03-21 07:09:52
Documents
13
Period of Report
2023-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d486527d8k.htm   iXBRL 8-K 25381
2 EX-99.1 d486527dex991.htm EX-99.1 55552
  Complete submission text file 0001193125-23-075232.txt   220266

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20230321.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20230321_lab.xml EX-101.LAB 19500
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20230321_pre.xml EX-101.PRE 12162
7 EXTRACTED XBRL INSTANCE DOCUMENT d486527d8k_htm.xml XML 3604
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 23747832
SIC: 2836 Biological Products, (No Diagnostic Substances)